BRIEF published on 11/24/2025 at 08:25, 10 days 22 hours ago Almonty renforce sa présence dans le tungstène avec l'acquisition d'un projet aux États-Unis. Sphene Capital Almonty Industries Projet Tungstène Expansion Du Marché Infrastructures Stratégiques
BRIEF published on 11/24/2025 at 08:25, 10 days 22 hours ago Almonty Expands Tungsten Focus with U.S. Project Acquisition Market Expansion Sphene Capital Almonty Industries Strategic Infrastructure Tungsten Project
PRESS RELEASE published on 11/24/2025 at 08:20, 10 days 22 hours ago Original-Research: Almonty Industries Inc. (von Sphene Capital GmbH): Buy Sphene Capital GmbH upgrades Almonty Industries Inc. to Buy with CAD 13.50 target price. Almonty expands to US with Gentung project, positioning as key tungsten supplier Sphene Capital GmbH Almonty Industries Inc. Tungsten Supplier Gentung Project CAD 13.50 Target Price
BRIEF published on 09/08/2025 at 08:05, 2 months 26 days ago Almonty Industries Inc. annonce des progrès stratégiques malgré des difficultés financières Résultats Financiers Almonty Industries Marché Du Tungstène Cotation Au Nasdaq Progrès Stratégique
BRIEF published on 09/08/2025 at 08:05, 2 months 26 days ago Almonty Industries Inc. Reports Strategic Progress Amid Financial Challenges Financial Results Nasdaq Listing Strategic Progress Almonty Industries Tungsten Market
PRESS RELEASE published on 09/08/2025 at 08:00, 2 months 26 days ago Original-Research: Almonty Industries Inc. (von GBC AG): Buy Almonty Industries Inc. strengthens strategic positioning with key developments and financial results review for the first half of 2025, amid a supply-driven tight tungsten market and notable achievements Strategic Positioning Almonty Industries Inc. Tungsten Market Achievements Financial Results Review
BRIEF published on 07/22/2025 at 14:07, 4 months 13 days ago Almonty Industries Inc. reçoit une nouvelle note d'achat de Sphene Capital Recommandation D'achat Réserves Minérales Almonty Industries Prix Cible Projet Sangdong
BRIEF published on 07/22/2025 at 14:07, 4 months 13 days ago Almonty Industries Inc. Receives Updated 'Buy' Rating from Sphene Capital Buy Recommendation Target Price Mineral Reserves Almonty Industries Sangdong Project
PRESS RELEASE published on 07/22/2025 at 14:02, 4 months 13 days ago Original-Research: Almonty Industries Inc. (von Sphene Capital GmbH): Buy Sphene Capital GmbH updates Almonty Industries Inc. report with higher reserve estimates and revised target price. Detailed analysis includes increased mineral reserves and potential for future conversions Target Price Mineral Reserves Sphene Capital Almonty Industries Reserve Estimates
BRIEF published on 07/21/2025 at 10:05, 4 months 14 days ago Écart d'évaluation : Almonty Industries Inc. contre MP Materials Corp. Minéraux Critiques Croissance De L'EBITDA Almonty Industries Tungstène Écart De Valorisation
Published on 12/05/2025 at 02:35, 4 hours 4 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 5 hours 39 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 7 hours 34 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 7 hours 39 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 03:30, 3 hours 8 minutes ago CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 6 hours 48 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 10 hours 13 minutes ago Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 10 hours 24 minutes ago Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 19:10, 11 hours 28 minutes ago SCHOTT Pharma’s preliminary results for fiscal year 2025; outlook for FY 2026 and update of mid-term guidance
Published on 12/04/2025 at 18:14, 12 hours 24 minutes ago Résiliation d'une convention conclue entre actionnaires
Published on 12/04/2025 at 18:00, 12 hours 39 minutes ago Informations relatives au nombre total de droits de vote et d’actions composant le capital social au 28 novembre 2025
Published on 12/04/2025 at 18:00, 12 hours 39 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 12 hours 54 minutes ago Informations relatives au nombre total de droits de vote et d’actions
Published on 12/04/2025 at 17:45, 12 hours 54 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
